tag drug-safety 
Healthcare IT Today
AUGUST 21, 2023
The following is a guest article by Peter Bloch, Market Development Manager – Healthcare at Avery Dennison Radio Frequency Identification (RFID) technology is revolutionizing healthcare, by improving efficiency, patient safety, and supply chain management. FDA’s Drug Supply Chain Security Act (DSCSA).
Healthcare IT Today
NOVEMBER 16, 2023
The following is a guest article by Jennifer Splawski, PharmD, MS, BCPS, Director of Clinical Strategy at Bluesight In the ever-evolving landscape of patient safety, a groundbreaking solution has emerged to combat medication errors and enhance operational efficiency in hospitals.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Aging in Place Technology Watch
DECEMBER 21, 2023
Senior living organizations showed signs of accelerating tech adoption, particularly in areas of AI for remote monitoring and safety. F rom Medicare Advantage supplemental benefits to savings on your prescription drugs, we will help you reduce your daily out-of-pocket expenses by finding validated ways to save. Learn more at RubyWell.
Healthcare IT Today
JUNE 29, 2023
Appendix I, Survey Procedures and Interpretive Guidelines for Life Safety Code Surveys, as well as Appendix Q, Guidelines for Determining Immediate Jeopardy, must be followed by all ASCs. ASCA members can view an ASC-specific surveyor tag tool. Medicare reimburses drugs and devices differently.
Healthcare IT News - Telehealth
JULY 16, 2020
Food and Drug Administration regulations, which require mifepristone, one of the medications used in abortion, to be dispensed at a clinic, hospital or medical office. Studies have shown that although mifepristone's safety record is superior to that of penicillin, it is more heavily restricted than opioids such as fentanyl.
Aging in Place Technology Watch
APRIL 15, 2020
The pets can help c alm anxiety and soothe those that are agitate, increase quality of life for those with dementia or who are socially isolated, and can improve behavior without the use of drugs." GreatCall Link helps keep friends and family updated on your health and safety. Learn more at Ageless Innovation.
Insulin Nation
SEPTEMBER 29, 2017
The drug is now licensed for use with adults with Type 1 diabetes and adults with Type 2 diabetes. In October 2016, the agency withheld approval and asked Novo Nordisk on safety data for Fiasp. The drug already has been on the market in Europe, Canada, and Germany.
Expert insights. Personalized for you.
85 
Let's personalize your content